|
For decades, paper has been the primary mechanism for collecting clinical trial data. However, paper-based systems lead to errors and inefficiencies. As clinical data volumes rise by 20% per annum, collecting source data on paper is no longer a viable option. Oracle Clinical Remote Data Capture provides an efficient, scalable electronic data capture system that emulates paper-based methods.
Oracle Remote Data Capture (RDC) is built upon the same data model as Oracle Clinical. This brings many benefits as the same data entry screens and edit checks are used by Oracle Clinical and Oracle RDC. Mixed mode trials become simple, as the data entered through RDC is stored in the same tables as the data entered through Oracle Clinical. There is no duplication of effort because the study only needs to be defined once in Oracle Clinical and then available to both applications. Oracle RDC can leverage all the power of a clinical data management back end and a fast setup of trials is possible by using the Oracle Clinical Global Library. Clinical report forms (CRFs) designed in Oracle Clinical can be made available in RDC instantly via the tight integration between Oracle Clinical and Oracle RDC. Deploying Oracle RDC as your remote data capture product will result in reduced training time for environments already using Oracle Clinical. Via the Oracle Clinical and Oracle RDC integration, lab data can be captured and surfaced in Oracle Clinical and displayed in the RDC interface.
In a recent study, conducted by Health Industry Insights, Oracle RDC customers cited five main categories in which they had realized a definitive performance increase based on their EDC investments. Those categories were form reuse, query reduction, database locking, project management, and site monitoring. Beyond these categories, companies also cited an increase in data availability and data quality (which improved the data analysis process) as benefits realized, but they were often unable to quantify these gains. Not all companies surveyed had formally computed their EDC benefits; however, those that had averaged an overall 17.5% clinical trial cost reduction from EDC.
|
